维普期刊资源整合服务平台（V6.5）

276篇 您的检索式：作者名="de jong BA"

选中清除导出查看参考文献查看引证文献引用追踪共14页首页上一页第1页下一页末页 /14 跳转

	题名	作者	年代	出处	被引量
1	阿尔茨海默病患者脑血流的动态调节显示文摘脑自动调节和压力反射敏感性是维持脑血流量的关键机制。该研究评估了这些调控机制在阿尔茨海默病导致的痴呆和轻度认知障碍患者中是否受到影响,因为这会增加降压治疗的风险。	刘青叶鹏 de Heus RAA de Jong DLK Sanders ML van Spijker GJ Oudegeest-Sander MH Hopman MT Lawlor BA Olde Rikkert MGM Claassen JAHR	2018	中华高血压杂志2018，26，8：	4
2	Theprognostic value of anti-cyclic citrullinated peptide antibody inpatients with recent-onset rheuma toid arthritis显示文摘	Kroot EJ De Jong BA Van leeuwen MA	2000	Arthritis Rheum2000，43，10：	1
3	Polymorphisms in or near tumour necrosis factor (TNF)-gene do not determine levels of endotoxin-induced TNF production 显示文摘	de Jong BA Westendorp RG Bakker AM	2002	Genes Immun2002，3，1：	1
4	The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide显示文摘	Schellekens GA Visser H de Jong BA		0，，1：	1
5	The giagnostic properties of rheumatoid antibodies recognizing acyclic citrullinated peptide显示文摘	Schellekengsg GA Visser H de JONG BA	2000	Arthritis Rheum2000，，1：	1
6	Psychometricproperties of the impact on participation and autonomy ques-tionnaire显示文摘	Cardol M de Haan RJ de Jong BA	2001	Archives of Physical Medicine and Rehabilitation2001，82，2：	1
7	The prognostic value of anti-cyclic citrul\|inated peptide antibody in patients with re- cent-onset rheumatoid arthritis 显示文摘	Kroot E J Jong DE Van Leeuwen BA M A	2000	Arthritis Rheum2000，43，12：	1
8	Low-dose predni- sone therapy for patients with early active rheumatoid arthritis:clini- cal efficacy,disease-modifying properties, and side effects 显示文摘	Kroot E J de Jong BA van Leeuwen MA	2002	Ann Intern Med2002，136，1：	1
9	Antibodies against cyclic citrullinated peptide and tgA rheumatoid factor predict the development of rheumatoid arthritis 显示文摘	Rantapaa-Dahlqvist S de Jong BA Berglin E	2003	Arthritis Rheum2003，48，10：	1
10	The diagnostic properlies of rheumatoid ar- thritis antibodies recognizing a cyclic citrulli- hated peptide 显示文摘	Schellekens GA Visser H De - Jong BA	2000	Arthritis and Rheumatism2000，43，1：	1
11	The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide 显示文摘	Schenekens GA Visser H de Jong BA	2000	Arthritis Rheum2000，43，1：	1
12	The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide显示文摘	Schellekens GA Visser H de Jong BA	2000	Arthritis Rheum2000，43，1：	1
13	The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide 显示文摘	Schellekens GA Visser H De Jong BA	2000	Arthritis Rheum2000，43，1：	1
14	Citrulline is an essential constituent of antigenic determi-nants recognized by rheumatoid arthritis-specific autoanti-bodies显示文摘	Schellekens GA de Jong BA Van Den Hoogen FH	1998	J Clin Invest1998，101，1：	1
15	The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide显示文摘	Schellekens GA Visser H de Jong BA	2000	Arthritis Rheum2000，43，1：	1
16	The diagnosetic properties of rhenmatiod atthritis antibodies recognizing a cyclic citmllinated peptide显示文摘	Schellekens GA Visser H De Jong BA	2000	Arthritis Rheum2000，43，1：	1
17	Frequency of functional interleukin-10 promoter polymorphism is different between relapse-onset and primary progressive multiple sclerosis显示文摘	de Jong BA Westendorp RG Eskdale J	2002	Hum Immunol2002，63，4：	1
18	The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic eitrullinated peptide 显示文摘	Schellekens GA Visser H de Jong BA	2000	Arthritis Rheum2000，43，1：	1
19	Shoulder disorders in general practice: Incidence,patient characteris- tics,and management 显示文摘	van der Windt DA Koes BW de Jong BA	1995	Annals of the rheumatic diseases1995，54，12：	1
20	Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis显示文摘	Rantapaa-Dahlqvist S de Jong BA Berglin E et a1	2003	Arthritis Rheum2003，48，：	1

返回顶部每页显示：

共14页首页上一页第1页下一页末页 /14 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示